Biotech

All Articles

Amgen records initial phase 3 gain for $400M chronic eczema drug

.Amgen has actually discussed (PDF) the first stage 3 data on its own $400 thousand dermatitis medic...

Biogen, UCB document phase 3 lupus succeed after neglecting earlier test

.Biogen as well as UCB's depend developing in to stage 3 on the back of a broken research study hope...

Aptadir hopes brand-new RNA inhibitors may reverse tricky cancers

.Italian biotech Aptadir Therapies has actually released along with the pledge that its pipe of prec...

Wave surfs DMD results to regulators' doors, sending stockpile

.Surge Life Sciences has met its goal in a Duchenne muscle dystrophy (DMD) research, placing it to t...

Sanofi tweezes brand new CSO from in-stealth biotech

.After a handful of years in biotech, Mike Quigley, Ph.D., is actually returning to the pharma layer...

Achilles splashes cell therapy course, braces for unemployments after missing 'office stability' targets

.Achilles Therapies has actually shreded its own method. The English biotech is quiting working on i...

Aligos trumpets stage 2 MASH win, reducing liver excess fat as much as 46%

.Aligos Therapeutics is actually heralding a midstage succeed in metabolic-dysfunction linked steato...

Basilea scores $268M BARDA financing for antifungals, antibiotics

.Basilea Pharmaceutica's work developing brand-new antifungals has actually gotten a significant inc...

Capricor sells Europe liberties to late-stage DMD treatment for $35M

.Possessing actually scooped up the united state legal rights to Capricor Therapies' late-stage Duch...

FDA junks adcomm for Applied's uncommon disease drug

.After dismissing the decision date for Applied Therapeutics' metabolic disorder drug govorestat, th...